GlassScriptPhysician profile
Ronghua Yang
NPI 1588198121
$37,679.79
in general payments reported to CMS, 2019-2025
9 companies · $8,230 in 2025
The $8,230 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $7,720 · 2023: $4,128 · 2024: $18K · 2025: $8,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $8,845 · Grant: $5,565 · Education: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,984.59 |
| Food and Beverage | $8,844.66 |
| Grant | $5,565.23 |
| Education | $565.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $11,128.11 | 2022-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Biomonitor |
| Boston Scientific Corporation | $10,510.40 | 2022-2024 | Watchman Access System, Versacross Access Solution, Emblem Mri S-Icd |
| Medtronic, INC. | $7,513.47 | 2022-2025 | Micra, Affera Mapping System |
| Abbott Laboratories | $5,888.24 | 2024 | Ensite Precision, Ensite |
| Philips North America LLC | $1,092.96 | 2025 | Igt Devices Undivided, Lm Undivided, Extended Holter |
| Biosense Webster, INC. | $1,035.08 | 2024-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Medical Device Business Services, INC. | $382.91 | 2024 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $99.00 | 2022 | |
| Merck Sharp & Dohme LLC | $29.62 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronghua Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.